Eribulin mesylate versus ixabepilone in patients with metastatic breast cancer: A randomized Phase II study comparing the incidence of peripheral neuropathy

Linda T. Vahdat, Agustin A. Garcia, Charles Vogel, Christine Pellegrino, Deborah L. Lindquist, Nicholas Iannotti, Prashanth Gopalakrishna, Joseph A. Sparano

Research output: Contribution to journal › Article › peer-review

53 Scopus citations

Fingerprint

Dive into the research topics of 'Eribulin mesylate versus ixabepilone in patients with metastatic breast cancer: A randomized Phase II study comparing the incidence of peripheral neuropathy'. Together they form a unique fingerprint.

Medicine & Life Sciences